Molecular Testing for MRSA and C. diff.: Using New Tools to Identify and Reduce HAIs
15 Nov 2012

For both economic and regulatory reasons, hospitals and other healthcare facilities are stepping up efforts to decrease healthcare-associated infection (HAI) rates. Clinical labs can be helpful in these initiatives, particularly in identifying methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium difficile (C. diff.) infections. This webinar discusses the new technologies that detect these pathogens more quickly and accurately than ever before, and how labs are incorporating them into their testing strategies and surveillance programs.